XML 93 R74.htm IDEA: XBRL DOCUMENT v3.25.1
Equity Compensation (Summary of Outstanding Options Vesting, Expected to Vest, or Exercisable) (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Mar. 25, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]      
Number of Options, Vested and expected to vest (in shares) 495    
Weighted Average Exercise Price, Vested and expected to vest (in dollars per share) $ 81.27    
Weighted Average Remaining Contractual Term, Vested and expected to vest 6 years 7 months 17 days    
Aggregate Intrinsic Value, Vested and expected to vest $ 9,404    
Number of Options, Exercisable (in shares) 337 500 500
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 74.72    
Weighted Average Remaining Contractual Term, Exercisable 5 years 10 months 13 days    
Aggregate Intrinsic Value, Exercisable $ 8,497